SL Science Holding SLBT
NASDAQ SLBT
$1.21 +0.02 (+1.68%)
At close: Oct 28, 2026 · 4:00 PM EDT

SL Science Holding (SLBT) Other Non-Current Liabilities (2026)

Updated

Analysis

SL Science Holding (SLBT) Other Non-Current Liabilities (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,213.59 Bn 1,182.17 Bn 19.71 Bn
2 Johnson & Johnson 652.89 Bn 572.75 Bn 17.30 Bn
3 AbbVie 506.16 Bn 479.31 Bn 12.70 Bn
4 Merck 347.97 Bn 302.40 Bn 12.21 Bn
5 Novartis Ag 297.84 Bn 271.42 Bn -
6 Astrazeneca 262.79 Bn 236.55 Bn 12.86 Bn
7 Amgen 244.26 Bn 199.66 Bn 7.24 Bn
8 Gilead Sciences 197.57 Bn 171.68 Bn 6.22 Bn
9 Pfizer 168.03 Bn 114.97 Bn 10.94 Bn
10 SL Science Holding 2.64 Bn 2.62 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Mn
API Access

SL Science Holding Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SLBT&period=max&api_key=YOUR_API_KEY